Cefazolin versus cephalothin in beta-lactamase-producing Staphylococcus aureus endocarditis in a rabbit experimental model.
D000818:Animals; D002437:Cefazolin / Q000627:therapeutic use*; D002512:Cephalothin / Q000627:therapeutic use*; D004697:Endocarditis, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D011817:Rabbits; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000201:enzymology; D013997:Time Factors; D001618:beta-Lactamases / Q000378:metabolism*
D001618:beta-Lactamases; D002437:Cefazolin; D002512:Cephalothin